Skip to main content

Advertisement

Log in

The Evaluation and Management of Persistent Nocturia

  • Lower Urinary Tract Symptoms & Voiding Dysfunction (H Goldman and G Badlani, Section Editors)
  • Published:
Current Urology Reports Aims and scope Submit manuscript

Abstract

Nocturia, or waking at night to void, is a common symptom that leads to substantial morbidity. Men and women are both affected across a wide age range, such that the objective evaluation of nocturia remains a challenge, due largely to its multifactorial etiology. While for some patients, nocturia is caused by common structural conditions such as prostatic obstruction, for others it is due to a complex interplay between multiple underlying systemic diseases. For this reason, persistent nocturia merits particularly careful consideration. The purpose of this review is to describe the most recent salient research in the field of nocturia, with a particular emphasis on its evaluation and management.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

References

Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. van Kerrebroeck P, Abrams P, Chaikin D, Donovan J, Fonda D, Jackson S, et al. The standardisation of terminology in nocturia: report from the Standardisation Sub-committee of the International Continence Society. Neurourol Urodyn. 2002;21(2):179–83.

    Article  PubMed  Google Scholar 

  2. Bosch JL, Weiss JP. The prevalence and causes of nocturia. J Urol. 2013;189(1 Suppl):S86–92. Comprehensive, accessible review of studies of nocturia prevalence, a measure which is otherwise difficult to interpret in a clinically applicable way.

    Article  PubMed  Google Scholar 

  3. Coyne KS, Sexton CC, Bell JA, Thompson CL, Dmochowski R, Bavendam T, et al. The prevalence of lower urinary tract symptoms (LUTS) and overactive bladder (OAB) by racial/ethnic group and age: results from OAB-POLL. Neurourol Urodyn. 2013;32(3):230–7.

    Article  PubMed  Google Scholar 

  4. Agarwal A, Eryuzlu LN, Cartwright R, Thorlund K, Tammela TL, Guyatt GH, et al. What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women. Eur Urol. 2014;65(6):1211–7.

    Article  PubMed Central  PubMed  Google Scholar 

  5. Torimoto K, Hirayama A, Matsushita C, Matsumoto Y, Yamada A, Fujimoto K, et al. Evaluation of sleep quantity and quality in older adults with nocturia using portable electroencephalogram acquisition device. J Urol. 2013;189(4):e557–8.

    Article  Google Scholar 

  6. Tasali E, Leproult R, Ehrmann DA, Van Cauter E. Slow-wave sleep and the risk of type 2 diabetes in humans. Proc Natl Acad Sci U S A. 2008;105(3):1044–9.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  7. Hall MH, Muldoon MF, Jennings JR, Buysse DJ, Flory JD, Manuck SB. Self-reported sleep duration is associated with the metabolic syndrome in midlife adults. Sleep. 2008;31(5):635–43.

    PubMed Central  PubMed  Google Scholar 

  8. Dew MA, Hoch CC, Buysse DJ, Monk TH, Begley AE, Houck PR, et al. Healthy older adults' sleep predicts all-cause mortality at 4 to 19 years of follow-up. Psychosom Med. 2003;65(1):63–73.

    Article  PubMed  Google Scholar 

  9. Temml C, Ponholzer A, Gutjahr G, Berger I, Marszalek M, Madersbacher S. Nocturia is an age-independent risk factor for hip-fractures in men. Neurourol Urodyn. 2009;28(8):949–52.

    Article  PubMed  Google Scholar 

  10. Cauley JA. Public health impact of osteoporosis. J Gerontol A Biol Sci Med Sci. 2013;68(10):1243–51.

    Article  PubMed  Google Scholar 

  11. Weiss JP, Blaivas JG, Blanker MH, Bliwise DL, Dmochowski RR, Drake M, et al. The New England Research Institutes, Inc. (NERI) Nocturia Advisory Conference 2012: focus on outcomes of therapy. BJU Int. 2013;111(5):700–16. Offers expert consensus positions on major recent developments in nocturia research.

    Article  PubMed  Google Scholar 

  12. Eid K, Krughoff K, Stoimenova D, Smith D, Phillips J, O'Donnell C, et al. Validation of the Urgency, Weak stream, Incomplete emptying, and Nocturia (UWIN) score compared with the American Urological Association Symptoms Score in assessing lower urinary tract symptoms in the clinical setting. Urology. 2014;83(1):181–5.

    Article  PubMed  Google Scholar 

  13. Kupelian V, McVary KT, Kaplan SA, Hall SA, Link CL, Aiyer LP, et al. Association of lower urinary tract symptoms and the metabolic syndrome: results from the Boston area community health survey. J Urol. 2013;189(1 Suppl):S107–14. discussion S15-6. Large study demonstrating that significant LUTS, including nocturia, are associated with an increased odds of the metabolic syndrome. Provides further evidence suggesting a possible common pathophysiology between LUTS and other chronic systemic diseases.

    Article  PubMed  Google Scholar 

  14. Endeshaw YW, Johnson TM, Kutner MH, Ouslander JG, Bliwise DL. Sleep-disordered breathing and nocturia in older adults. J Am Geriatr Soc. 2004;52(6):957–60.

    Article  PubMed  Google Scholar 

  15. Hung SF, Chung SD, Kuo HC. Increased serum C-reactive protein level is associated with increased storage lower urinary tract symptoms in men with benign prostatic hyperplasia. PLoS One. 2014;9(1):e85588.

    Article  PubMed Central  PubMed  Google Scholar 

  16. Thurmon KL, Breyer BN, Erickson BA. Association of bowel habits with lower urinary tract symptoms in men: findings from the 2005-2006 and 2007-2008 National Health and Nutrition Examination Survey. J Urol. 2013;189(4):1409–14.

    Article  PubMed Central  PubMed  Google Scholar 

  17. Breyer BN, Kenfield SA, Blaschko SD, Erickson BA. The association of lower urinary tract symptoms, depression and suicidal ideation: data from the 2005-2006 and 2007-2008 National Health and Nutrition Examination Survey. J Urol. 2014;191(5):1333–9.

    Article  PubMed Central  PubMed  Google Scholar 

  18. Laumann EO, Kang JH, Glasser DB, Rosen RC, Carson CC. Lower urinary tract symptoms are associated with depressive symptoms in white, black and Hispanic men in the United States. J Urol. 2008;180(1):233–40.

    Article  PubMed  Google Scholar 

  19. Goessaert AS, Schoenaers B, Opdenakker O, Hoebeke P, Everaert K, Walle JV. Long-term followup of children with nocturnal enuresis: increased frequency of nocturia in adulthood. J Urol. 2014. doi:10.1016/j.juro.2013.12.051.

    PubMed  Google Scholar 

  20. Obayashi K, Saeki K, Kurumatani N. Association between melatonin secretion and nocturia in elderly individuals: a cross-sectional study of the HEIJO-KYO cohort. J Urol. 2013. doi:10.1016/j.juro.2013.12.043.

    PubMed  Google Scholar 

  21. Cornu JN, Abrams P, Chapple CR, Dmochowski RR, Lemack GE, Michel MC, et al. A contemporary assessment of nocturia: definition, epidemiology, pathophysiology, and management–a systematic review and meta-analysis. Eur Urol. 2012;62(5):877–90.

    Article  PubMed  Google Scholar 

  22. Gulur DM, Mevcha AM, Drake MJ. Nocturia as a manifestation of systemic disease. BJU Int. 2011;107(5):702–13.

    Article  PubMed  Google Scholar 

  23. Vaughan CP, Johnson 2nd TM, Haukka J, Cartwright R, Howard ME, Jones KM, et al. The fluctuation of nocturia in men with lower urinary tract symptoms allocated to placebo during a 12-month randomized, controlled trial. J Urol. 2014;191(4):1040–4. Large study suggesting that nocturia prevalence may remain stable in an eldelry cohort over 1-year, possibly supporting early conservative management.

    Article  PubMed  Google Scholar 

  24. Tani M, Hirayama A, Torimoto K, Matsushita C, Yamada A, Fujimoto K. Guidance on water intake effectively improves urinary frequency in patients with nocturia. Int J Urol. 2014;21:595–600.

    PubMed  Google Scholar 

  25. Tyagi S, Resnick NM, Perera S, Monk TH, Hall MH, Buysse DJ. Behavioral treatment of insomnia: also effective for nocturia. J Am Geriatr Soc. 2014;62(1):54–60.

    Article  PubMed Central  PubMed  Google Scholar 

  26. Johnson 2nd TM, Markland AD, Goode PS, Vaughan CP, Colli JL, Ouslander JG, et al. Efficacy of adding behavioural treatment or antimuscarinic drug therapy to alpha-blocker therapy in men with nocturia. BJU Int. 2013;112(1):100–8.

    Article  CAS  PubMed  Google Scholar 

  27. Bae WJ, Bae JH, Kim SW, Chung BH, Kim JH, Kim CS, et al. Desmopressin add-on therapy for refractory nocturia in men receiving alpha-blockers for lower urinary tract symptoms. J Urol. 2013;190(1):180–6.

    Article  CAS  PubMed  Google Scholar 

  28. Eisenhardt A, Schneider T, Cruz F, Oelke M. Consistent and significant improvement of nighttime voiding frequency (nocturia) with silodosin in men with LUTS suggestive of BPH: pooled analysis of three randomized, placebo-controlled, double-blind phase III studies. World J Urol. 2014. doi:10.1007/s00345-013-1228-7.

    PubMed  Google Scholar 

  29. Tacklind J, Fink HA, Macdonald R, Rutks I, Wilt TJ. Finasteride for benign prostatic hyperplasia. Cochrane Database Syst Rev. 2010;10, CD006015.

    PubMed  Google Scholar 

  30. Hamidi Madani A, Enshaei A, Heidarzadeh A, Mokhtari G, Farzan A, Mohiti Asli M, et al. Transurethral intraprostatic Botulinum toxin-A injection: a novel treatment for BPH refractory to current medical therapy in poor surgical candidates. World J Urol. 2013;31(1):235–9.

    Article  CAS  PubMed  Google Scholar 

  31. Falahatkar S, Mokhtari G, Pourreza F, Asgari SA, Kamran AN. Celecoxib for treatment of nocturia caused by benign prostatic hyperplasia: a prospective, randomized, double-blind, placebo-controlled study. Urology. 2008;72(4):813–6.

    Article  PubMed  Google Scholar 

  32. Weiss JP, Jumadilova Z, Johnson 2nd TM, Fitzgerald MP, Carlsson M, Martire DL, et al. Efficacy and safety of flexible dose fesoterodine in men and women with overactive bladder symptoms including nocturnal urinary urgency. J Urol. 2013;189(4):1396–401.

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  33. Oelke M, Weiss JP, Mamoulakis C, Cox D, Ruff D, Viktrup L. Effects of tadalafil on nighttime voiding (nocturia) in men with lower urinary tract symptoms suggestive of benign prostatic hyperplasia: a post hoc analysis of pooled data from four randomized, placebo-controlled clinical studies. World J Urol. 2014. doi:10.1007/s00345-014-1255-z.

    Google Scholar 

  34. Friedman FM, Weiss JP. Desmopressin in the treatment of nocturia: clinical evidence and experience. Ther Adv Urol. 2013;5(6):310–7.

    Article  PubMed Central  PubMed  Google Scholar 

  35. Sand PK, Dmochowski RR, Reddy J, van der Meulen EA. Efficacy and safety of low dose desmopressin orally disintegrating tablet in women with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J Urol. 2013;190(3):958–64.

    Article  CAS  PubMed  Google Scholar 

  36. Weiss JP, Herschorn S, Albei CD, van der Meulen EA. Efficacy and safety of low dose desmopressin orally disintegrating tablet in men with nocturia: results of a multicenter, randomized, double-blind, placebo controlled, parallel group study. J Urol. 2013;190(3):965–72. Initial study providing dose recommendations for newly-formulated desmopressin ODT. Results suggest that a low dose may offer clinically significant benefits with an improved safety profile.

    Article  CAS  PubMed  Google Scholar 

  37. Yamaguchi O, Nishizawa O, Juul KV, Norgaard JP. Gender difference in efficacy and dose response in Japanese patients with nocturia treated with four different doses of desmopressin orally disintegrating tablet in a randomized, placebo-controlled trial. BJU Int. 2013;111(3):474–84.

    Article  CAS  PubMed  Google Scholar 

  38. Juul KV, Klein BM, Norgaard JP. Long-term durability of the response to desmopressin in female and male nocturia patients. Neurourol Urodyn. 2013;32(4):363–70.

    Article  CAS  PubMed  Google Scholar 

  39. Kwon O, Lee HE, Bae J, Oh JK, Oh SJ. Effect of holmium laser enucleation of prostate on overactive bladder symptoms and urodynamic parameters: a prospective study. Urology. 2014;83(3):581–5.

    Article  PubMed  Google Scholar 

  40. Wada N, Numata A, Hou K, Watanabe M, Kita M, Matsumoto S, et al. Nocturia and sleep quality after transurethral resection of the prostate. Int J Urol. 2014;21(1):81–5.

    PubMed  Google Scholar 

Download references

Compliance with Ethics Guidelines

Conflict of Interest

Dr. Dima Raskolnikov, Dr. Fara M. Friedman, and Dr. Dhanan J. Etwaru each declare no potential conflicts of interest.

Dr. Jeffrey P. Weiss reports personal fees from Ferring, Pfizer, Astellas, Allergan, and Vantia.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Jeffrey P. Weiss.

Additional information

This article is part of the Topical Collection on Lower Urinary Tract Symptoms & Voiding Dysfunction

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Raskolnikov, D., Friedman, F.M., Etwaru, D.J. et al. The Evaluation and Management of Persistent Nocturia. Curr Urol Rep 15, 439 (2014). https://doi.org/10.1007/s11934-014-0439-9

Download citation

  • Published:

  • DOI: https://doi.org/10.1007/s11934-014-0439-9

Keywords

Navigation